References
- Batlle E , Bacant J, Begthel H, et al (2005). EphB receptor activity suppresses colorectal cancer progression. Nature, 435, 1126-30. https://doi.org/10.1038/nature03626
- Chan KM, Yu MC, Lee WC, Jan YY, Chen MF (2007). Adenosquamous/squamous cell carcinoma of gallbladder. J Surg Oncol, 95, 129-34. https://doi.org/10.1002/jso.20576
- Chen J, Zhuang G, Frieden L, Debinski W (2008). Eph receptors and Ephrins in cancer: common themes and controversies. Cancer Res, 68, 10031-3. https://doi.org/10.1158/0008-5472.CAN-08-3010
- Davalos V, Dopeso H, Castano J, et al (2006). EphB4 and survival of colorectal cancer patients. Cancer Res, 66, 8943-8. https://doi.org/10.1158/0008-5472.CAN-05-4640
- Eph Nomenclature Committee (1997). Unified nomenclature for Eph family receptors and their ligands, the ephrins. Cell, 90, 403. https://doi.org/10.1016/S0092-8674(00)80500-0
- Fu T, Li P, Wang H, et al (2009). c-Rel is a transcriptional repressor of EPHB2 in colorectal cancer. J Pathol, 219, 103-13. https://doi.org/10.1002/path.2590
- Genander M, Halford MM, Xu NJ, et al (2009). Dissociation of EphB2 signaling pathways mediating progenitor cell proliferation and tumor suppression. Cell, 139, 679-92. https://doi.org/10.1016/j.cell.2009.08.048
- Guo DL, Zhang J, Yuen ST, et al (2006). Reduced expression of EphB2 that parallels invasion and metastasis in colorectal tumours. Carcinogenesis, 27, 454-64. https://doi.org/10.1093/carcin/bgi259
- Hamdani NH, Qadri SK, Aggarwalla R, et al (2012). Clinicopathological study of gallbladder carcinoma with special reference to gallstones:our 8-year experience from eastern India. Asian Pac J Cancer Prev, 13, 5613-7. https://doi.org/10.7314/APJCP.2012.13.11.5613
-
Huang J, Xiao D, Li G, et al (2013). EphA2 promotes epithelialmesenchymal transition through the Wnt/
${\beta}$ -catenin pathway in gastric cancer cells. Oncogene, 10, 238. - Jubb AM, Zhong F, Bheddah S, et al (2005). EphB2 is a prognostic factor in colorectal cancer. Clin Cancer Res, 11, 5181-7. https://doi.org/10.1158/1078-0432.CCR-05-0143
- Kalita D, Pant L, Singh S, et al (2013). Impact of routine histopathological examination of gall bladder specimens on early detection of malignancy - a study of 4,115 cholecystectomy specimens. Asian Pac J Cancer Prev, 14, 3315-8. https://doi.org/10.7314/APJCP.2013.14.5.3315
- Kapoor VK (2006). Gallbladder cancer: a global perspective. J Surg Oncol, 93, 607-9. https://doi.org/10.1002/jso.20525
- Kayaharan M, Nagakawa T (2007). Recent trends of gallbladder cancer in Japan: an analysis of 4, 770 patients. Cancer, 110, 572-80. https://doi.org/10.1002/cncr.22815
- Kim WS, Jang KT, Choi DW, et al (2011). Clinicopathologic analysis of adenosquamous /squamous cell carcinoma of the gallbladder. J Surg Oncol, 103, 239-42. https://doi.org/10.1002/jso.21813
- Kumar JR, Tewari M, Rai A, el al (2006). An objective assessment of demography of gallbladder cancer. Surg Oncol, 93, 610-4. https://doi.org/10.1002/jso.20526
- Lugli A, Spichtin H, Maurer R, et al (2005). EphB2 expression across 138 human tumor types in a tissue microarray: high levels of expression in gastrointestinal cancers. Clin Cancer Res, 11, 6450-8. https://doi.org/10.1158/1078-0432.CCR-04-2458
- Mao YY, Jing FY, Jin MJ, et al (2013). rs12904 polymorphism in the 3'UTR of EFNA1 is associated with colorectal cancer susceptibility in a Chinese population. Asian Pac J Cancer Prev, 14, 5037-41. https://doi.org/10.7314/APJCP.2013.14.9.5037
- Miao H, Li DQ, Mukherjee A, et al (2009). EphA2 mediates ligand-dependent inhibition and ligand-independent promotion of cell migration and invasion via a reciprocal regulatory loop with Akt. Cancer Cell, 16, 9-20. https://doi.org/10.1016/j.ccr.2009.04.009
- Murai KK, Pasquale EB (2003). 'Eph'ective signaling: forward, reverse and crosstalk. J Cell Sci, 116, 2823-32. https://doi.org/10.1242/jcs.00625
- Nakada M, Niska JA, Tran NL, McDonough WS, Berens ME (2005). EphB2/R-Ras signaling regulates glioma cell adhesion, growth, and invasion. Am J Pathol, 167, 565-76. https://doi.org/10.1016/S0002-9440(10)62998-7
- Nakada M, Niska JA, Miyamori H, et al (2004). The phosphorylation of EphB2 receptor regulates migration and invasion of human glioma cells. Cancer Res, 64, 3179-85. https://doi.org/10.1158/0008-5472.CAN-03-3667
- Palmer A, Klein R (2003). Multiple roles of ephrins in morphogenesis, neuronal networking, and brain function. Genes Dev, 17, 1429-50. https://doi.org/10.1101/gad.1093703
- Senior PV, Zhang BX, Chan ST (2010). Loss of cell-surface receptor EphB2 is important for the growth, migration, and invasiveness of a colon cancer cell line. Int J Colorectal Dis, 25, 687-94. https://doi.org/10.1007/s00384-010-0916-7
- Wu Q, Suo Z, Risberg B, et al (2004). Expression of Ephb2 and Ephb4 in breast carcinoma. Pathol Oncol Res, 10, 26-33. https://doi.org/10.1007/BF02893405
Cited by
- Galectin-9: An anticancer molecule for gallbladder carcinoma vol.48, pp.3, 2016, https://doi.org/10.3892/ijo.2016.3347